Results 91 to 100 of about 1,580,053 (264)

Thermo Scientific Smart EPU Software: Towards autonomous screening [PDF]

BIO Web of Conferences
Grollios Fanis, Kohr Holger, Ortiz Julio, Pryor Edward   +3 more
doaj   +1 more source

A Review of Molecular Dynamics Simulation of Different Ti-Al-Based Alloys

Metals
Ti-Al-based alloys, particularly two-phase TiAl and Ti3Al alloys, have garnered significant attention as potential replacements for various high-temperature structural materials due to their exceptional properties, including low density, oxidation ...
Ningning Li, Zhenjie Hao, Lei Xu, Mingqi Tang, Leyu Wei, Lifei Wang   +5 more
doaj   +1 more source

Materials Genomics Search for Possible Helium-Absorbing Nano-Phases in Fusion Structural Materials. [PDF]

Adv Sci (Weinh), 2022
Xu H, Kim SY, Chen D, Monchoux JP, Voisin T, Sun C, Li J.   +6 more
europepmc   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Features of the Medium Term Outlook for the Production of Structural Materials in Russia. [PDF]

Stud Russ Econ Dev, 2022
Budanov IA.
europepmc   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Robust flexural performance and fracture behavior of TiO₂ decorated densified bamboo as sustainable structural materials. [PDF]

Nat Commun, 2023
Ba Z, Luo H, Guan J, Luo J, Gao J, Wu S, Ritchie RO.   +6 more
europepmc   +1 more source

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Evaluation of Physico-Mechanical Properties and Thermal Conduction to Energy-Saving Effects of Wood Compression Layered Structural Materials. [PDF]

Polymers (Basel), 2023
Chen YH, Ho ST, Lin HC.
europepmc   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source